DLL1 and breast cancer: This mAb binds to DLL1 protein with a calculated kinetic affinity of 4.78 nM, but not to the other human ligands of the Notch pathway, and recognizes cellular DLL1 in DLL1-overexpressing cells and ER+ BC tumor tissues.